TB Research

Antibiotic Cycling Reverts Extensive Drug Resistance in Burkholderia multivorans

Logan G. Kavanaugh, S. K. Harrison, J. Nicole Flanagan, Todd R. Steck

Antimicrobial Agents and Chemotherapy · 2021-06

Abstract

Antibiotic collateral sensitivity, in which acquired resistance to one drug leads to decreased resistance to a different drug, occurs in Burkholderia multivorans. Here, we observed that treatment of extensively drug-resistant variants evolved from a cystic fibrosis (CF) sputum sample isolate with either meropenem or sulfamethoxazole-trimethoprim, depending on past resistance phenotypes, resulted in increased sensitivity to five different classes of antibiotics. We further identified mutations, including putative resistance-nodulation-division efflux pump regulators and uncharacterized pumps, that may be involved in this phenotype in B. multivorans.

MeSH terms

  • Antibiotics
  • Microbiology
  • Efflux
  • Biology
  • Drug resistance
  • Meropenem
  • Sputum
  • Trimethoprim
  • Burkholderia
  • Antibiotic resistance